| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | 6.66e-04 | 891 | 10 | 4 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.97e-03 | 1189 | 10 | 4 | GO:0046914 | |
| GeneOntologyBiologicalProcess | oocyte development | 8.03e-04 | 99 | 9 | 2 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 8.69e-04 | 103 | 9 | 2 | GO:0009994 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.98e-03 | 156 | 9 | 2 | GO:0048477 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 2.15e-03 | 163 | 9 | 2 | GO:0031507 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 3.32e-03 | 203 | 9 | 2 | GO:0045814 | |
| GeneOntologyBiologicalProcess | female gamete generation | 3.98e-03 | 223 | 9 | 2 | GO:0007292 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 8.53e-03 | 330 | 9 | 2 | GO:0040029 | |
| Domain | DUF4371 | 2.58e-06 | 5 | 10 | 2 | PF14291 | |
| Domain | DUF4371 | 2.58e-06 | 5 | 10 | 2 | IPR025398 | |
| Domain | zf-FCS | 5.41e-06 | 7 | 10 | 2 | PF06467 | |
| Domain | Znf_MYM | 5.41e-06 | 7 | 10 | 2 | IPR010507 | |
| Domain | TRASH | 7.21e-06 | 8 | 10 | 2 | SM00746 | |
| Domain | TRASH_dom | 7.21e-06 | 8 | 10 | 2 | IPR011017 | |
| Domain | RNaseH-like_dom | 5.94e-04 | 69 | 10 | 2 | IPR012337 | |
| Domain | ZF_RING_1 | 1.00e-02 | 291 | 10 | 2 | PS00518 | |
| Domain | ZF_RING_2 | 1.05e-02 | 298 | 10 | 2 | PS50089 | |
| Domain | RING | 1.10e-02 | 305 | 10 | 2 | SM00184 | |
| Domain | Znf_RING | 1.25e-02 | 326 | 10 | 2 | IPR001841 | |
| Domain | Znf_RING/FYVE/PHD | 2.38e-02 | 459 | 10 | 2 | IPR013083 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 1.78e-03 | 294 | 10 | 2 | chr1p34 | |
| GeneFamily | Zinc fingers MYM-type | 4.13e-06 | 6 | 10 | 2 | 86 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 5.59e-05 | 207 | 10 | 3 | M1963 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 6.98e-05 | 223 | 10 | 3 | MM838 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.08e-04 | 119 | 10 | 2 | d7a8f4089d4dfbf9226513818cc8430bc6fa8cf2 | |
| ToppCell | BAL-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 3.18e-04 | 121 | 10 | 2 | b49b044a687a31883dfccecf10a183b5ba567f7a | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 3.96e-04 | 135 | 10 | 2 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 140 | 10 | 2 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 140 | 10 | 2 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 140 | 10 | 2 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.26e-04 | 140 | 10 | 2 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 4.26e-04 | 140 | 10 | 2 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.44e-04 | 143 | 10 | 2 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.44e-04 | 143 | 10 | 2 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.82e-04 | 149 | 10 | 2 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 152 | 10 | 2 | 653e3dc80c54c16730c5ba0187fc1f663761fc87 | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 5.01e-04 | 152 | 10 | 2 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.41e-04 | 158 | 10 | 2 | 551e3fd7cabc94ba933607ccdcf93f4e799be43a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 162 | 10 | 2 | 9dca585c734faea0e1122c70f5dc36cef3dbd2c6 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 5.97e-04 | 166 | 10 | 2 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-04 | 166 | 10 | 2 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 6.12e-04 | 168 | 10 | 2 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-04 | 168 | 10 | 2 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 6.26e-04 | 170 | 10 | 2 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 171 | 10 | 2 | 7ca404539344e14dcd90c746c9122f713a7db78b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 171 | 10 | 2 | ab113c8e773b0af47a87aed50e96be3ba71c3c82 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.33e-04 | 171 | 10 | 2 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.41e-04 | 172 | 10 | 2 | b84610f1e5889a655652800c2b3270d264bfe1a9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.48e-04 | 173 | 10 | 2 | 12c6875f881cb0fbff09d753b53c1cce7a95527f | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 6.56e-04 | 174 | 10 | 2 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.78e-04 | 177 | 10 | 2 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 6.86e-04 | 178 | 10 | 2 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.94e-04 | 179 | 10 | 2 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.94e-04 | 179 | 10 | 2 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 7.09e-04 | 181 | 10 | 2 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 7.17e-04 | 182 | 10 | 2 | 02e04294fce12591c32d7bd0e866a000ad1f836e | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 7.33e-04 | 184 | 10 | 2 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.41e-04 | 185 | 10 | 2 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.41e-04 | 185 | 10 | 2 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 7.48e-04 | 186 | 10 | 2 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 7.48e-04 | 186 | 10 | 2 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.48e-04 | 186 | 10 | 2 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-04 | 188 | 10 | 2 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.65e-04 | 188 | 10 | 2 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | Control-Other|Control / Disease, Lineage and Cell Type | 7.81e-04 | 190 | 10 | 2 | 3be5497909b48bf05c623586880f225bb101b430 | |
| ToppCell | Control-Other-RBC|Control / Disease, Lineage and Cell Type | 7.81e-04 | 190 | 10 | 2 | 35b254564d01c839c63f9af159a46d368852cf15 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-04 | 191 | 10 | 2 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 7.89e-04 | 191 | 10 | 2 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-04 | 191 | 10 | 2 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-04 | 191 | 10 | 2 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.97e-04 | 192 | 10 | 2 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.97e-04 | 192 | 10 | 2 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.97e-04 | 192 | 10 | 2 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.97e-04 | 192 | 10 | 2 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.14e-04 | 194 | 10 | 2 | 0117cd68750153fd6b8978c8b4ce3589486d2b5f | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.14e-04 | 194 | 10 | 2 | bb36274d6fe2d18c545a17d3809f331586502d01 | |
| ToppCell | medial-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.14e-04 | 194 | 10 | 2 | d58be6454a0795d6771036a1620553a153861615 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.22e-04 | 195 | 10 | 2 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.30e-04 | 196 | 10 | 2 | 170629b9ae82e9a911b93e8739dcd38176fbecb4 | |
| ToppCell | distal-1-Hematologic-Plasmacytoid_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.39e-04 | 197 | 10 | 2 | 166d47359df9279ea8c3946f10bd3d4b88c95857 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.47e-04 | 198 | 10 | 2 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 8.47e-04 | 198 | 10 | 2 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 7.10e-05 | 195 | 10 | 3 | 6903_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 7.43e-05 | 198 | 10 | 3 | 7235_DN | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 2.91e-04 | 76 | 10 | 2 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | periodontitis | 2.46e-03 | 223 | 10 | 2 | EFO_0000649 | |
| Disease | hypertension | 4.59e-03 | 307 | 10 | 2 | EFO_0000537 | |
| Disease | lymphocyte count | 1.12e-02 | 1464 | 10 | 3 | EFO_0004587 | |
| Disease | hemoglobin A1 measurement | 1.27e-02 | 520 | 10 | 2 | EFO_0007629 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSQCKQTYYCSTACQ | 181 | Q9BXT4 | |
| TYNTTCCNKDNCNSA | 86 | O95867 | |
| CKCCCTASSNLNCYY | 76 | Q8IWZ5 | |
| TCTNTVDSYYCACKQ | 46 | Q14246 | |
| YCSQCHYSSITKNCL | 771 | Q9P243 | |
| SQCGSTTLSYTCYCC | 36 | Q8WW36 | |
| TMNCCENCGSYCYSS | 231 | O95789 | |
| CCENCGTYCYTSSSL | 231 | Q5SVZ6 | |
| CVYNYYKTACCASCT | 991 | Q6ZMP0 | |
| ACSQCSQCYHPYCVN | 1396 | O14686 |